New research published today in Proceedings of the National Academy of Sciences (PNAS) finds that prolonged and/or repeated ...

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid ...

In a study, patients with irritable bowel syndrome with diarrhea, or IBS-D, who went on a low FODMAP diet saw an improvement ...

The cerebral cortex processes sensory information via a complex network of neural connections. How are these signals ...

Researchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center (MECCC), ...

A new study by investigators from Mass General Brigham examined the effects of policies banning flavored e-cigarettes on ...

A new study in Nature shows that delivering a single injection of gene therapy at birth may offer years-long protection ...

Wastewater surveillance at treatment plants offers a low-cost, early warning method for detecting COVID-19. Researchers in ...

Liver cancer cells thrive on fat, posing a serious risk of cancer diagnosis for millions of people living with fatty liver disease.

A comprehensive new review reveals both the promise and challenges of using fecal microbiota transplantation (FMT) to enhance cancer immunotherapy effectiveness.

A global study reveals that cutting-edge cancer immunotherapies, while lifesaving, carry a hidden risk: they may trigger cholestasis, a serious liver condition where bile flow stalls.